Table 2 Descriptive data and number of subjects used for the analysis
From: Inflammation and cell-to-cell communication, two related aspects in frailty
Total | non-Frail | Frail | P | |
|---|---|---|---|---|
CRP plasma analysis | ||||
N | 129 | 64 | 65 | |
Age(years) | 76,67 (± 1,38) | 76.70 (± 1.34) | 76.65 (± 1.42) | 0.815 |
Education (years) | 7.06 (± 3.59) | 7.64 (± 3.89) | 6.49 (± 3.19) | 0.069 |
Frailty Index (0–1) | 0.24 (± 0.18) | 0.042 (± 0.03) | 0.3635 (± 0.11) | < 0.001 |
Female % | 49.6 | 50 | 49.2 | 0.930 |
Meso Scale Discoveryfor cytokines analysis | ||||
N | 128 | 63 | 65 | |
Age(years) | 76,67 (± 1,37) | 76,70 (± 1,38) | 76,65 (± 1,42) | 0.830 |
Education (years) | 7,09 (± 3,55) | 7,71 (± 3,82) | 6,49 (± 3,19) | 0.520 |
Frailty Index (0–1) | 0.21 (± 0.18) | 0.04 (± 0.03) | 0.36 (± 0.11) | < 0.001 |
Female % | 50 | 50.8 | 49.2 | 0.860 |
lEVs analysis | ||||
N | 40 | 20 | 20 | |
Age(years) | 76.60 (± 1.35) | 76,50 (± 1,28) | 76,70 (± 1,45) | 0.647 |
Education (years) | 7.08 (± 3.93) | 7,60 (± 4,41) | 6,55 (± 3,41) | 0.406 |
Frailty Index (0–1) | 0.20 (± 0.21) | 0.01 (± 0.007) | 0.3941 (± 0.10) | < 0.001 |
Female % | 45 | 35 | 55 | 0.341a |